Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Graybug Vision Inc (GRAY)

Graybug Vision Inc (GRAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,638
  • Shares Outstanding, K 1,571
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,610 K
  • 60-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.24
Trade GRAY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings $-0.46 on 11/10/22
  • Latest Earnings Date 03/23/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -6.30
  • Number of Estimates 1
  • High Estimate -6.30
  • Low Estimate -6.30
  • Prior Year -5.74
  • Growth Rate Est. (year over year) -9.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.00 +10.00%
on 03/20/23
9.24 -40.48%
on 02/22/23
-3.28 (-37.39%)
since 02/17/23
3-Month
5.00 +10.00%
on 03/20/23
10.62 -48.23%
on 01/17/23
-1.01 (-15.51%)
since 12/20/22
52-Week
5.00 +10.00%
on 03/20/23
22.12 -75.13%
on 03/21/22
-12.42 (-69.31%)
since 03/18/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, FMIA, GRAY

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BLI : 1.2000 (-5.88%)
GRAY : 5.50 (-10.80%)
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Graybug Vision, Inc. (NasdaqGM: GRAY) with...

GRAY : 5.50 (-10.80%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ELVT : 1.8700 (+0.54%)
IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
USER : 7.50 (-0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
APEN : 10.00 (+0.81%)
SAL : 27.88 (+1.57%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RBA, WAFD, OPNT, GRAY

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RBA : 76.98 (+0.30%)
WAFD : 28.91 (+0.14%)
OPNT : 20.65 (-0.58%)
GRAY : 5.50 (-10.80%)
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Graybug Vision, Inc. (NasdaqGM: GRAY) with...

GRAY : 5.50 (-10.80%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, OPNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ELVT : 1.8700 (+0.54%)
IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
OPNT : 20.65 (-0.58%)
Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica

/PRNewswire/ -- Ademi LLP is investigating Graybug (Nasdaq: GRAY) for possible breaches of fiduciary duty and other violations of law in its transaction with...

GRAY : 5.50 (-10.80%)
GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Graybug Vision, Inc. (NASDAQ: GRAY) and CalciMedica Inc. is fair to Graybug shareholders.

GRAY : 5.50 (-10.80%)
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments

BALTIMORE, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing...

GRAY : 5.50 (-10.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Graybug Vision Inc. is a clinical-stage biopharmaceutical company. It is focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve. The company's product candidate includes GB-102, GB-401 and GB-103 which are in clinical stage. Graybug Vision...

See More

Key Turning Points

3rd Resistance Point 7.13
2nd Resistance Point 6.61
1st Resistance Point 6.05
Last Price 5.50
1st Support Level 4.97
2nd Support Level 4.45
3rd Support Level 3.89

See More

52-Week High 22.12
Fibonacci 61.8% 15.58
Fibonacci 50% 13.56
Fibonacci 38.2% 11.54
Last Price 5.50
52-Week Low 5.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar